News

Potential Bidders Emerge for Intel's Altera Business Stakes

Potential Bidders Emerge for Intel's Altera Business Stakes

Strategic Interest in Intel's Altera Business

Major private equity firms, especially Silver Lake and Bain Capital, are currently in discussions regarding the opportunity to acquire a minority stake in Altera. This programmable chips business was acquired by Intel for nearly $17 billion in 2015, and new prospects are emerging as Intel prepares to possibly spin Altera off as a separate entity.

Recent Developments in Stake Sale

In recent weeks, Intel has initiated a stake sale process, signaling a transformative shift for Altera. Initial bids from interested buyers are anticipated shortly, illustrating the strong market interest in this technology-focused business. It’s worth noting that Francisco Partners, a notable private equity firm, has also shown interest in participating in the acquisition.

Valuation Expectations for Altera

Intel is reportedly looking for a valuation for Altera similar to what it originally paid during its acquisition. Discussions are still in preliminary stages, meaning outcomes remain uncertain, but indications suggest that any deal would likely be substantial, potentially amounting to several billion dollars.

Performance Insights

Altera has demonstrated growth in its operations, with a reported 14% increase in revenue, reaching $412 million for the quarter ending September 30. This suggests that despite challenges in manufacturing, Altera continues to generate significant income. CEO Pat Gelsinger has expressed optimism about bringing in investors to support Altera's journey towards a public offering in the near future.

Reasons Behind Intel's Strategic Moves

The motivation behind Intel’s decision stems from a broader perspective of cost management and restructuring. With its stock value declining significantly and the company missing out on the AI boom, Intel is seeking avenues to optimize expenses. Selling stakes in non-core businesses like Altera is a tactical approach to ensure operational efficiency.

Challenges with Production Shifts

An important backdrop to this situation is Altera's transition under Intel’s ownership. Before being integrated into Intel, Altera’s chips were primarily produced by Taiwan Semiconductor Manufacturing Co, marking a significant shift when Intel took production in-house. This transition proved difficult and resulted in Altera losing its competitive footing against rivals like Xilinx, which was eventually acquired by Advanced Micro Devices.

Future Outlook for Altera

As Intel navigates its transformation and the competitive landscape, the future of Altera hangs in the balance. With ongoing discussions and a potential IPO on the horizon, the interest from firms like Silver Lake, Bain Capital, and Francisco Partners could redefine Altera's trajectory in the programmable chip market.

Frequently Asked Questions

What companies are interested in acquiring a stake in Altera?

Private equity firms Silver Lake and Bain Capital are leading potential bidders for a stake in Altera.

What is the valuation Intel expects for Altera?

Intel hopes to achieve a valuation for Altera that is similar to the nearly $17 billion it paid at the time of acquisition.

How did Altera perform recently in terms of revenue?

Altera posted a revenue increase of 14%, amounting to $412 million for the quarter ending September 30.

What challenges has Altera faced under Intel's ownership?

Altera struggled with the transition of chip production to Intel's factories, leading to a loss of market share against competitors.

What are the long-term plans for Altera?

Intel is exploring a path for Altera that may lead to an initial public offering (IPO) in the coming years.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Liberty Hill: 50 Years of Grassroots Revolution

Updated Category News Views 4

Half a Century of Community Empowerment You don't see organizations sticking to their guns for fifty years without having something real to offer. Liberty Hill Foundation is celebrating this colossal milestone in style by throwing their weight behind 17 grassroots groups under the 2026 Fund for Change. They're not just tossing money around but are genuinely becoming the...

Continue Reading
Bitwise Pulls Plug on Dogecoin ETF Amid Market Risks

Updated Category News Views 6

Bitwise Ditches Dogecoin ETF: End of a Speculative Era Who knew that a digital asset inspired by an internet meme would get a platform on Wall Street? Well, Bitwise did. They rallied behind Dogecoin, launching the Bitwise Dogecoin ETF, ticker BWOW. But as of September 10, 2026, the fund's journey is coming to an end with liquidation just around the corner. What Sparked...

Continue Reading
Red-Eye Flights Surge, Driven By Western U.S. Routes

Updated Category News Views 5

You can always count on some things staying the same, right? Well, if you thought red-eye flights were going to fade away, think again. These late-night wonders are not just hanging around—they're booming in the west like there's no tomorrow. Literally. Champion Traveler has laid it all out for us: about 115,580 overnight flights in 2025, a record high since this mad...

Continue Reading
Rare Collectibles Highlight Morphy's Auction on Oct 4

Updated Category News Views 2

Anticipation Builds for Morphy's Auction Event Morphy's upcoming event on October 4th is all about tapping into the era of revved engines, gleaming gasoline signs, and some history that could put Hollywood tales to shame. The auction isn't just a stroll down memory lane; it features over 650 lots, each a time capsule of America's automotive past. From Al Capone's ritzy...

Continue Reading
AbbVie's Bold Leap in Menstrual Migraine Treatment

Updated Category News Views 10

AbbVie's Game-Changing Atogepant Study When it comes to pushing boundaries in the pharmaceutical world, there's no sitting on the fence. AbbVie's Phase 3 LUNA study results are painting a bright picture for women who suffer from the relentless grip of menstrual migraines. In a world where not a single treatment option has been approved specifically for this condition,...

Continue Reading
Veteran Marketer Joins The Wisory's Advisory Board

Updated Category News Views 3

Tyrrell Schmidt Joins The Wisory's Board Out of the blue, The Wisory has snatched Tyrrell Schmidt right off the retirement bench. This doesn't seem like just another board seating; it smells like a calculated power play. Schmidt, fresh from her heavyweight stint as Global CMO at TD Bank, adds a spicy dose of marketing prowess to The Wisory's already loaded Advisory Board....

Continue Reading
Seismic Pharma Kicks Off Phase 3 Trial for Istaroxime

Updated Category News Views 3

Seismic Sets the Stage for a Medical Milestone From the heart of biotech in Durham, North Carolina, seismic waves ripple through the medical community as Seismic Pharmaceuticals embarks on a high-stakes adventure. It's official: they've enrolled their very first patient in the global Phase 3 trial of istaroxime, targeting the grim specter known as cardiogenic shock. You...

Continue Reading
XKL Delivers MediaLight for High-Speed Optical Transport

Updated Category News Views 2

Unpacking the MediaLight Launch Kicking off September, XKL is tossing its hat in the ring with the MediaLight Xponder and Muxponder systems. These aren't just any run-of-the-mill gizmos—nope, they're touted as top-of-the-line optical transport solutions. The talk of the town is their ability to dish out high-density 100G and 400G transport, and for geeks in the trade,...

Continue Reading
CrossCountry Mortgage Boosts Loan Limits, Flexibility for 2027

Updated Category News Views 13

Trailblazing in the Mortgage Game Well, what do we have here? CrossCountry Mortgage, the big cheese of retail mortgage lenders, is cranking up their conforming loan limits to a hefty $845,000. They're jumping the gun on the Federal Housing Finance Agency's official 2027 announcement. It's a classic move—proactive, bold, and a bit of a gamble, if you ask me. They’re...

Continue Reading
Flex Dental Solutions Adds BNPL, Surcharging to FlexPayments

Updated Category News Views 5

Diving into Dental Finances: A New Moneymaker? It's about time someone shook up the dental payment scene, and Flex Dental Solutions seems to be the one doing it. They rolled out some intriguing new features for their FlexPayments platform aimed squarely at dental practices using Open Dental. What we're seeing here is their attempt to bridge a couple of financial headaches...

Continue Reading

Top 5 Most Recently Viewed Articles

Meiji Seika Pharma Expands KOSTAIVE® Manufacturing In Japan

Updated Category News Views 394

Meiji Seika Pharma Enhances Manufacturing Capabilities Meiji Seika Pharma Co., Ltd., known for its commitment to healthcare, has recently received exciting approval to expand its manufacturing and marketing capabilities for the innovative self-amplifying mRNA vaccine, KOSTAIVE®. This decision marks a significant milestone for the company as it strengthens the local...

Continue Reading
OS Therapies Achieves Milestone in Osteosarcoma Treatment

Updated Category News Views 246

An Exciting Breakthrough in Osteosarcoma Treatment OS Therapies, Inc. (NYSE-A: OSTX), a pioneering biotechnology firm, has recently made waves in the oncology field by completing a Phase 2b clinical trial concerning its innovative treatment, OST-HER2. This trial aims to address the severe challenges faced by patients suffering from lung metastatic osteosarcoma - a rare...

Continue Reading
CEO Andy Byron Takes Leave Following Coldplay Concert Incident

Updated Category News Views 381

CEO Andy Byron Takes Leave Amidst Viral Coldplay Incident Astronomer CEO Andy Byron is currently on leave due to a controversial situation that unfolded during a Coldplay concert. A video that circulated online appears to show Byron embracing the company’s HR head, Kristin Cabot, which ignited a social media frenzy. The Viral Video's Impact The footage, which originated...

Continue Reading
Misunderstood Whiskey's Exciting Launch of Orange Blossom Bourbon

Updated Category News Views 234

Misunderstood Whiskey Launches Orange Blossom Bourbon Misunderstood Whiskey Co. has announced the launch of their eagerly awaited Orange Blossom Bourbon. This marks a significant milestone as it is the brand's first bourbon since it began in 2017. With this release, the company aims to revolutionize the flavored whiskey market by providing high-quality, infused options...

Continue Reading
Impact of Capital Flows on Emerging Markets: A Cautionary Analysis

Updated Category News Views 352

Capital Flow Challenges for Emerging Economies The dynamics of capital flows have become a significant topic of discussion lately, with emerging markets facing potential hurdles that could alter their financial landscape dramatically. Recent insights from JPMorgan, an influential investment bank, shed light on these pressing issues. As economic policies shift globally,...

Continue Reading